ArticleBlood advances2019

Increased Mac-2 binding protein glycan isomer in patients at risk for late nonrelapse mortality after HSCT.

Yu Akahoshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.